Major Players in India Angina Market | Top Companies & Insights 2026

Major Players in India Angina Market

India angina market is a specialized segment of the country's cardiovascular therapeutics industry, focused on managing chest pain caused by coronary artery disease. Key players in the market are Sun Pharmaceutical Industries, Cipla, Lupin, Torrent Pharmaceuticals, and AstraZeneca.

India Angina Market Overview

According to 6Wresearch, the India angina market is witnessing steady growth due to increasing prevalence of coronary artery disease, aging population, and rising awareness of preventive cardiac care. Expanding healthcare infrastructure, improved diagnosis rates, and wider availability of affordable generics are supporting market expansion. The increasing dependence of physicians on long term anti-anginal therapy and government focus on non-communicable disease management are further strengthening demand across urban and semi-urban regions.

Competitive Landscape

The competitive landscape in the India angina market comprises leading domestic pharmaceutical companies and global cardiovascular drug manufacturers competing through pricing strategies, formulation innovation, and strong distribution networks. These companies focus on chronic cardiac care portfolios, hospital partnerships, retail pharmacy penetration, and consistent medicine availability.

Leading Players Operating in the India Angina Market:

1. Sun Pharmaceutical Industries

A dominant force in cardiovascular health, Sun Pharma provides high-efficacy therapeutic formulations that support large-scale ischemic management and improve patient quality of life.

2. Cipla

A research-driven firm that integrates sophisticated API development with streamlined formulation to provide robust and reliable ischemic relief solutions.

4. Torrent Pharmaceuticals

Focuses on advanced therapeutic delivery, offering optimized solutions tailored for the specific metabolic and circulatory needs of diverse cardiac patient groups.

5. Sanofi

Integrates international clinical research standards with local healthcare needs, delivering stable and consistent anti-anginal agents for daily patient maintenance.

6. Zydus Lifesciences

Provides high-durability pharmaceutical processing and cardiovascular management, supporting critical care frameworks throughout the Indian healthcare sector.

7. Glenmark Pharmaceuticals

A platform that leverages manufacturing precision to provide reliable anti-anginal therapy and specialized cardiac support for diverse hospital networks.

8. Aurobindo Pharma

Supports the healthcare sector by providing consistent, high-standard cardiovascular formulations, ensuring stability for vital heart care services.

9. Alkem Laboratories

A leader in essential medicine production, Alkem focuses on providing widely accessible and therapeutically stable cardiac medications for the diverse Indian demographic.

10. Intas Pharmaceuticals

Combines specialty formulation engineering with robust distribution networks, offering targeted cardiac relief mechanisms designed for long-term health maintenance.

11. Ipca Laboratories

Leverages deep API expertise to provide stable, reliable cardiovascular drug delivery systems, supporting medical practitioners with high-efficacy treatment options.

12. Cadila Pharmaceuticals

Provides high-standard pharmaceutical processing and management, supporting comprehensive cardiovascular health programs across diverse national medical networks.

Major Players in India Angina Market: FAQs